BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27875319)

  • 1. Enhanced oral bioavailability of metoprolol with gallic acid and ellagic acid in male Wistar rats: involvement of CYP2D6 inhibition.
    Athukuri BL; Neerati P
    Drug Metab Pers Ther; 2016 Dec; 31(4):229-234. PubMed ID: 27875319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced oral bioavailability of linagliptin by the influence of gallic acid and ellagic acid in male Wistar albino rats: involvement of p-glycoprotein inhibition.
    Shaik M; Vanapatla SR
    Drug Metab Pers Ther; 2019 Jun; 34(2):. PubMed ID: 31256062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Oral Bioavailability of Diltiazem by the Influence of Gallic Acid and Ellagic Acid in Male Wistar Rats: Involvement of CYP3A and P-gp Inhibition.
    Athukuri BL; Neerati P
    Phytother Res; 2017 Sep; 31(9):1441-1448. PubMed ID: 28766866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol.
    Swaisland HC; Ranson M; Smith RP; Leadbetter J; Laight A; McKillop D; Wild MJ
    Clin Pharmacokinet; 2005; 44(10):1067-81. PubMed ID: 16176119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oral bioavailability, excretion and cytochrome P450 inhibition properties of epiberberine: an in vivo and in vitro evaluation.
    Chen N; Yang XY; Guo CE; Bi XN; Chen JH; Chen HY; Li HP; Lin HY; Zhang YJ
    Drug Des Devel Ther; 2018; 12():57-65. PubMed ID: 29343943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.
    Bramer SL; Suri A
    Clin Pharmacokinet; 1999; 37 Suppl 2():41-51. PubMed ID: 10702886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of CYP2D6 content and metoprolol oxidation between microsomes isolated from human livers and small intestines.
    Madani S; Paine MF; Lewis L; Thummel KE; Shen DD
    Pharm Res; 1999 Aug; 16(8):1199-205. PubMed ID: 10468020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metoprolol-pridopidine drug-drug interaction and food effect assessments of pridopidine, a new drug for treatment of Huntington's disease.
    Rabinovich-Guilatt L; Steiner L; Hallak H; Pastino G; Muglia P; Spiegelstein O
    Br J Clin Pharmacol; 2017 Oct; 83(10):2214-2224. PubMed ID: 28449367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of suberoylanilide hydroxamic acid on rat cytochrome P450 enzyme activities.
    Lin K; Zhang Q; Liu Z; Yang S; Lin Y; Wen C; Zheng Y
    Int J Clin Exp Pathol; 2015; 8(5):5584-90. PubMed ID: 26191268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
    Zineh I; Beitelshees AL; Gaedigk A; Walker JR; Pauly DF; Eberst K; Leeder JS; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hydroxychloroquine on the bioavailability of oral metoprolol.
    Somer M; Kallio J; Pesonen U; Pyykkö K; Huupponen R; Scheinin M
    Br J Clin Pharmacol; 2000 Jun; 49(6):549-54. PubMed ID: 10848718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic model incorporating mechanism-based inactivation of CYP2D6 can explain both non-linear kinetics and drug interactions of paroxetine.
    Mikami A; Ohtani H; Hori S; Sawada Y
    Int J Clin Pharmacol Ther; 2013 May; 51(5):374-82. PubMed ID: 23357843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation and dose adjustment of metoprolol after metoprolol-paroxetine/fluoxetine co-prescription in Dutch elderly.
    Bahar MA; Wang Y; Bos JHJ; Wilffert B; Hak E
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):621-629. PubMed ID: 29575226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism-Based Inactivation of CYP2D6 by Phellopterin and Related Drug-Drug Interaction with Metoprolol.
    Cheng Z; He Y; Chen Y; Zhao G; Liu Y; Zhang J; Li X; Ran G; Zhang Q; Peng Y; Li W; Zheng J
    J Agric Food Chem; 2024 Jan; 72(3):1745-1755. PubMed ID: 38214270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lotus leaf alkaloid fraction can strongly inhibit CYP2D6 isoenzyme activity.
    Ye LH; Kong LT; Yan MZ; Cao FR; Wang LS; Liao YH; Pan RL; Chang Q
    J Ethnopharmacol; 2016 Dec; 194():913-917. PubMed ID: 27771456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the potent CYP2D6 inhibitor sarpogrelate on the pharmacokinetics and pharmacodynamics of metoprolol in healthy male Korean volunteers.
    Cho DY; Bae SH; Lee JK; Park JB; Kim YW; Lee S; Oh E; Kim BT; Bae SK
    Xenobiotica; 2015 Mar; 45(3):256-63. PubMed ID: 25268386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro CYP2D Inhibitory Effect and Influence on Pharmacokinetics and Pharmacodynamic Parameters of Metoprolol Succinate by Terminalia arjuna in Rats.
    Varghese A; Savai J; Mistry S; Khandare P; Barve K; Pandita N; Gaud R
    Drug Metab Lett; 2016; 10(2):124-35. PubMed ID: 26891872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically Based Pharmacokinetic Modeling to Assess the Impact of CYP2D6-Mediated Drug-Drug Interactions on Tramadol and O-Desmethyltramadol Exposures via Allosteric and Competitive Inhibition.
    Long T; Cristofoletti R; Cicali B; Michaud V; Dow P; Turgeon J; Schmidt S
    J Clin Pharmacol; 2022 Jan; 62(1):76-86. PubMed ID: 34383318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Zuojin Pill on the Metabolism of Venlafaxine in Vitro and in Rats and Associated Herb-Drug Interaction.
    Li Y; Li J; Yan D; Wang Q; Jin J; Tan B; Qiu F
    Drug Metab Dispos; 2020 Oct; 48(10):1044-1052. PubMed ID: 32561594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.